Understanding the shifting US regulatory landscape: insights for drug developers
Boyds’ Dr Katherine Bowen, Chief Regulatory Affairs Officer and Dr Eric Hardter, Director of Regulatory Affairs, explore some of the key changes and provide advice for drug developers navigating the complexities of the regulatory landscape.